| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_65f6765a6f0387cfcb75bc6a09213161 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D221-22 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D221-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28 |
| filingDate |
1996-10-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2003-11-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_189f3b75671b1fbdd18b110c3feb3f76
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_70541336e876f1b4cd7690975f05035c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b6e7b8ced0bac0d8e75d39100bc3c433
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1f7becabaf8f61138378a452145ae27c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4089168a64b44b1785bb096229552263
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_03c14c9b9c3d9b45812a8098743ac395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_090a05fd34591b6aece5d968dca2d9fc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e05a2a22f086fa171ac91b3013a61d10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_134323cac48a00995343c376d055b5d0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c429fa49ccada9f3a5ae150f2a869f28 |
| publicationDate |
2003-11-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-0796849-B1 |
| titleOfInvention |
Novel polycyclic aminopyridine compounds as acetylcholinesterase inhibitors, preparation process and use thereof |
| abstract |
New polycyclic aminopyridine compounds which are acetylcholinesterase inhibitors, process for preparing them and their use. The polycyclic aminopyridine compounds correspond to the formula <CHEM> in which the various radicals have the meanings stated in the specification. The process for preparing these compounds is characterized in that ketones of general formula (II) are reacted with aminonitriles of general formula (III) and, if necessary, the compounds of formula (I) are alkylated, aralkylated or acylated, or alternatively the corresponding keto precursor is reduced. The compounds of the general formula (I) are especially suitable for the preparation of medicaments against memory disorders such as senile dementia or Alzheimer's disease. |
| priorityDate |
1995-10-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |